The authors showed that tumors such as head and neck, renal, and lung cancer, are highly affected by EGFR overexpressing mechanisms, in percentages between 80–100% for head and neck cancer, 50–90% for renal cancer, and 40–80% for lung cancer. The gene discussed is EGFR; the disease is lung carcinoma.